Back

Clinical considerations for ATTR-CM treatment timing with a TTR stabiliser

28 August 2026 (10:22 - 10:40)
Organised by: Logo
Congress Presentation Part of: Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing Cardiac Amyloidosis Open Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Prem Soman

Upmc University Of Pittsburgh Medical Center, Pittsburgh (United States of America)

Photo
Doctor Nicole Cyrille-Superville

Charlotte (United States of America)

4 More presentations in this session

Presentation thumbnail
Opening address and introduction to ATTR-CM
Associate Professor R. Pfister (Cologne, DE)
Presentation thumbnail
Importance of timely detection of ATTR-CM
Doctor M. Hanna (Cleveland, US)
Presentation thumbnail
Emerging artificial intelligence approaches to ATTR-CM screening
Doctor R. Khera (New Haven, US) Professor C. Lam (Singapore, SG)
Presentation thumbnail
Time matters in ATTR-CM: emerging artificial intelligence approaches to screening and clinical considerations for treatment timing - discussion and closing

Access the full session

Session thumbnail
Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing

The Event

Event poster

ESC Congress 2026

28 August 2026 10:22 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources